Science Explorer Interactive view Map
Company · Salt Lake City · United States

Q Therapeutics (United States)

qthera.comROR OpenAlex
Research works
116
▲ 86% vs 2013–17
Citations
1.5k
13.2 per fractional work
Top-10% rate
13.7%
record average 16.5%
Open access
50%
world 28%

Not ranked overall: Q Therapeutics (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.14× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 7.39× its world share, 18 worksBiochemistry, Geneti…Immunology and Microbiology: 10.00× its world share, 5 worksImmunology and Micro…Neuroscience: 1.25× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 2.77× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.32× its world share, 1 worksChemistryComputer Science: 0.07× its world share, 0 worksComputer ScienceEnvironmental Science: 0.02× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.07× its world share, 0 worksMaterials ScienceMedicine: 1.82× its world share, 16 worksMedicineArts and Humanities: 2.56× its world share, 3 worksArts and HumanitiesPsychology: 0.48× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 10.0×. Every wedge is a field page.

Who are the top researchers at Q Therapeutics (United States)?

Ranked on the composite score, Dante J. Marciani and Dipen Sangurdekar lead among researchers whose main affiliation is Q Therapeutics (United States).

  1. 1 Dante J. Marciani United States · #795,432 worldwide 43 citations · 18 works
  2. 2 Dipen Sangurdekar United States · #1,560,118 worldwide 11 citations · 16 works
All ranked researchers at Q Therapeutics (United States)

Which keywords describe research at Q Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Cancer, Inflammation, Cancer Immunotherapy, Immunotherapy, Genome Engineering, RNA-Guided, Tumor Regression and Tumor Microenvironment.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Cancer5▲ 8.9×16 topics
  2. Inflammation5▲ 5.4×19 topics
  3. Cancer Immunotherapy4▲ 58×2 topics
  4. Immunotherapy4▲ 13×9 topics
  5. Genome Engineering4▲ 128×1 topic
  6. RNA-Guided4▲ 128×1 topic
  7. Tumor Regression4▲ 73×2 topics
  8. Tumor Microenvironment3▲ 16×5 topics
  9. Cancer Therapy3▲ 12×8 topics
  10. Glycosylation3▲ 59×3 topics
  11. CAR T Cells3▲ 83×1 topic
  12. Chimeric Antigen Receptor3▲ 83×1 topic
  13. Innate Immunity2▲ 17×4 topics
  14. Homologous Recombination2▲ 119×2 topics
  15. Metabolism2▲ 8.9×5 topics
  16. Cultural Heritage2▲ 8.0×3 topics
  17. Immunity2▲ 11×3 topics
  18. Transcriptional Regulation2▲ 27×4 topics
  19. Cell Death2▲ 18×4 topics
  20. Fc Receptors2▲ 76×1 topic
  21. Gene Therapy2▲ 22×3 topics
  22. Therapeutic Antibodies2▲ 60×1 topic
  23. Immune Checkpoint Blockade2▲ 34×1 topic
  24. PD-1 and PD-L12▲ 34×1 topic
  25. Angiogenesis2▲ 11×5 topics
  26. Genomic Instability2▲ 31×2 topics
  27. Targeted Therapy2▲ 15×5 topics
  28. Diabetes2▲ 6.7×4 topics
  29. Antigen Presentation1▲ 35×2 topics
  30. Chromatin1▲ 65×2 topics
  31. DNA Damage1▲ 40×2 topics
  32. ATM and ATR Kinases1▲ 126×1 topic
  33. Dendritic Cells1▲ 32×1 topic
  34. Linguistics1▲ 18×1 topic
  35. Nuclear Receptors1▲ 33×2 topics
  36. Repair1▲ 126×1 topic
  37. Sufism1▲ 59×2 topics
  38. Tumor Antigen1▲ 47×1 topic
  39. Turkic1▲ 104×1 topic
  40. Cell Signaling1▲ 17×4 topics

Which research topics does Q Therapeutics (United States) publish most on?

By volume in 2022–2025: CRISPR and Genetic Engineering, CAR-T cell therapy research, Monoclonal and Polyclonal Antibodies Research and Cancer Immunotherapy and Biomarkers.

CRISPR and Genetic Engin…4CRISPR and Genetic Engineering: 4 fractional worksCAR-T cell therapy research: 3 fractional worksMonoclonal and Polyclona…2Monoclonal and Polyclonal Antibodies Research: 2 fractional worksCancer Immunotherapy and…2Cancer Immunotherapy and Biomarkers: 2 fractional worksDNA Repair Mechanisms: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksLinguistics and Cultural…1Linguistics and Cultural Studies: 1 fractional worksPARP inhibition in cancer therapy: 1 fractional worksVirus-based gene therapy research: 1 fractional worksPeroxisome Proliferator-Activated Receptors: 1 fractional works
Molecular BiologyOncologyRadiology, Nuclear Medicine and ImagingImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 CRISPR and Genetic Engineering Molecular Biology 4 works
  2. 2 CAR-T cell therapy research Oncology 3 works
  3. 3 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 2 works
  4. 4 Cancer Immunotherapy and Biomarkers Oncology 2 works
  5. 5 DNA Repair Mechanisms Molecular Biology 1 works
  6. 6 Immunotherapy and Immune Responses Immunology 1 works
  7. 7 Linguistics and Cultural Studies Language and Linguistics 1 works
  8. 8 PARP inhibition in cancer therapy Oncology 1 works
  9. 9 Virus-based gene therapy research Genetics 1 works
  10. 10 Peroxisome Proliferator-Activated Receptors Molecular Biology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available50.1%not open49.9%

World: 28% of research is openly available.

with international co-authors20.3%domestic only79.7%

World: 19% is written across borders.

How has Q Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 86% higher than in 2013–2017.

199520002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Salt Lake City

All research institutions in Salt Lake City

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.